BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. At BioMarin, we are committed to transforming lives through genetic discovery. At BioMarin, patients are at the heart of what we do.

Applying our knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The end goal has always been better lives and now we can reach more. And the more people we reach, the more our impact can grow. The BioMarin page is a place to connect with and learn about our company. We will provide company news and updates, as well as share stories from our patients. Our goal is to engage with our community by providing useful and interesting information, and fostering open and respectful dialogues about the diseases we seek to treat. While we are committed to fostering important relevant discussions and respect the rights of everyone to voice their opinions, we ask that users/followers of our social media channels are respectful to other members and follow our Community Guidelines. See our full Community Guidelines here: https://www.facebook.com/BioMarinOfficial/app/145740286161845

We’re excited to share that registration for Camp Ellellbee – an adaptive camp offered by The Little Legs Big Heart Foun...
04/13/2026

We’re excited to share that registration for Camp Ellellbee – an adaptive camp offered by The Little Legs Big Heart Foundation and supported by BioMarin – is now open!

More than a weekend retreat, Camp Ellellbee serves as a platform for fostering community, making space for facilitating meaningful relationships and providing support to families navigating genetic skeletal conditions.

This year, camps will take place in Winder, Georgia (Aug. 21-23), Casco, Maine (Aug. 28-30), Boulder Creek, California (Sept. 11-13), Burton, Texas (Oct. 2-4) and Park City, Utah (Oct. 16-18).

Learn more and reserve your spot for one of this year's camps by registering here: http://ms.spr.ly/6181Q7p4D

At the age of 16, Bridget Yates lost her first role model when her grandmother died due to complications with Alzheimer’...
03/31/2026

At the age of 16, Bridget Yates lost her first role model when her grandmother died due to complications with Alzheimer’s disease. It was the second death she experienced in a two-week span. But that summer also marked new beginnings, as she started working at Stanford Hospital, a place where her scientific curiosity could flourish.

“Her illness and eventual passing profoundly impacted my perspective, leading to a pivotal shift in my focus and setting my trajectory pointing straight towards medicine,” recounts Bridget.

Read more about Bridget’s passion for purposeful science, her commitment to patients, and how she is helping to shape BioMarin’s future through her compassionate leadership: http://ms.spr.ly/6182QIjhk

Colleagues in our Research and Early Development (RED) department recently presented their work during our RED Scientifi...
03/30/2026

Colleagues in our Research and Early Development (RED) department recently presented their work during our RED Scientific Poster Session, an annual opportunity to come together and celebrate the curiosity and collaboration that fuel our innovation.

The session took place at our San Rafael headquarters, inside the hallways of our labs, and showcased some of the scientific and technological approaches that support the advancement of our therapeutic pipeline — all in a setting designed to spark dialogue and connection.

Congratulations to this year’s poster award winners, whose work stood out for scientific rigor, clarity and impact. And thank you to everyone who participated, attended and helped make this event a meaningful opportunity to connect and spark the kind of dialogue that can help drive the next wave of ideas.

03/27/2026

As we continue making progress toward the close of our pending acquisition of Amicus Therapeutics, today we published an open letter from our CEO Alexander Hardy and Chief Corporate Affairs & Patient Advocacy Officer Marni Kottle to officially introduce BioMarin to the global Pompe and Fabry communities. We look forward to engaging more directly with these communities once Amicus officially becomes part of BioMarin.

Read the open letter on our website: http://ms.spr.ly/6188QvgRY

Terri Christianson has been at BioMarin since just after its founding in 1997. More than 10,000 days have passed since s...
03/24/2026

Terri Christianson has been at BioMarin since just after its founding in 1997. More than 10,000 days have passed since she started her journey here, but the days that stand out most to Terri have one thing in common.

“It’s always inspiring when patients visit,” says Terri, Director of Biologics Production and Molecular Analytics Lead in Modality. “Meeting patients face to face reminds our team why our work matters and lets us share the science behind what we do. It’s a powerful connection.”

Hear more from Terri and some of her colleagues on our R&D teams about the full-circle moments when our researchers have the opportunity to meet the people whose lives have been impacted by BioMarin’s science: http://ms.spr.ly/6189QtdnZ

The BioMarin Women’s Alliance (BWA) encouraged its members to share their experiences at BioMarin and discuss how engagi...
03/19/2026

The BioMarin Women’s Alliance (BWA) encouraged its members to share their experiences at BioMarin and discuss how engaging employees around occasions such as International Women’s Day and Women's History Month helps foster a sense of belonging. Read more from Sydney Cortez, Ana María Bermúdez Cabas, Francis Rosete, Kelsey Gonzales and Erika D’Egidio as they share their perspectives about what it means to be part of BWA.

Several of our team members met with advocates, legislators and community leaders this week in Phoenix, where Arizona be...
03/17/2026

Several of our team members met with advocates, legislators and community leaders this week in Phoenix, where Arizona became the first state in the nation to host a Rare Skeletal Conditions Advocacy Day at its State Capitol. It was a meaningful moment to listen, learn and stand alongside a community that continues to lead with resilience and purpose. Advocates were also recognized on the floor of the Arizona House of Representatives.

We had the opportunity to hear from community leaders Kristen DeAndrade and Tammy Bowers, whose firsthand perspectives and lived experiences helped shape important conversations throughout the day. BioMarin’s Michael Ash, who leads our skeletal conditions business unit and was born and raised in Arizona, also spoke, underscoring the importance of improving care for people living with rare conditions statewide, while also working toward global progress. Joan Koerber-Walker, who leads AZBio, spoke about Arizona’s growing bioscience ecosystem and the opportunity for Arizona to be a leader in access to innovations such as whole genome sequencing.

Discussions also focused on the importance of expanding access to genetic testing, including the opportunity to expand access to newborn genomic screening for rare conditions with FDA‑approved treatments.

We appreciate the chance to learn from the community and look forward to continuing to amplify these voices. Thank you to the Little Legs Big Heart Foundation, the Noonan Syndrome Foundation and AZBio for sponsoring this important opportunity to help advance progress for people living with rare genetic skeletal conditions in Arizona.

03/09/2026

Our Signature Science campaign spotlights employees from across our company, inviting them to reflect on their personal journeys – and the unique mark they make on our science. When asked what’s most rewarding about working at BioMarin, our colleagues spoke to something powerful: seeing our science translate into real, life-changing impact for people living with rare genetic conditions.

Hear directly from Christina Pao, Donnie Mackenzie, Joyanna Hansen and Javier Femenia about how purpose, passion and science come together at BioMarin to make a difference for patients who are counting on us.

Explore the full Signature Science series here: https://www.youtube.com/playlist?list=PLxkyzokcP73-pxMKk7nHmZkiHW8Psl56x

Ahead of International Women’s Day, the BioMarin Women’s Alliance (BWA) organized a series of events designed to inspire...
03/08/2026

Ahead of International Women’s Day, the BioMarin Women’s Alliance (BWA) organized a series of events designed to inspire, empower, and support women and girls. On Friday, guest speaker Sharon Delaney McCloud, hosted a workshop focused on strengthening executive presence and influential communication. Participants learned tools to amplify their voice, overcome bias and distractions, and project confidence in a variety of professional settings.

At our Novato campus, employees volunteered with Scientific Adventures for Girls (SAfG) to assemble STEM lesson kits for the organization’s spring break camp, helping support the next generation of female scientists.

Colleagues also coordinated a community volunteer event in partnership with Girls With Impact that was designed to help high school girls build confidence and career readiness through resume feedback and mentorship.

As we join people around the world in recognizing International Women’s Day, we extend our gratitude to BWA and all who participated in these events for exemplifying this year’s theme of in helping advance gender equity.

Meet Daria Bujnicka, who is studying Environmental Engineering at Warsaw University of Life Sciences and is one of the s...
03/05/2026

Meet Daria Bujnicka, who is studying Environmental Engineering at Warsaw University of Life Sciences and is one of the stars of Poland’s para-badminton team. Alongside her doubles partner, she won gold at the 2025 European Championships and medals at the World Championships in 2022, 2024 and 2026.

Daria is an ambassador for , a campaign created by BioMarin in partnership with multiple patient advocacy organizations, including the Poland-based Stowarzyszenie na rzecz dzieci z achondroplazją. Daria joins others living with skeletal conditions participating in the campaign by sharing moments from her daily life with achondroplasia, from navigating the city on public transport and shopping for clothes and groceries, to cooking with family and spending time with friends.

“Achondroplasia means I sometimes take a different route to reach my goals, but I always reach them," she says. "I do things differently sometimes, but I never see that as a setback. Competing internationally in para badminton while studying at university has taught me resilience and focus. Through the campaign, I want to give people a real insight into life with achondroplasia and show that our ambitions are just as big as anyone else’s.”

Huge thanks to Daria for sharing a glimpse into her daily life with achondroplasia, and to Stowarzyszenie na rzecz dzieci z achondroplazją for collaborating on in Poland.

With the start of Women’s History Month, our BioMarin Women’s Alliance (BWA) Employee Resource Group (ERG) co-chairs Emm...
03/02/2026

With the start of Women’s History Month, our BioMarin Women’s Alliance (BWA) Employee Resource Group (ERG) co-chairs Emma Bolton and Rebecca Millward shared what they’re looking forward to and why this year’s International Women’s Day theme – – resonates with them. We’re anticipating an exciting month filled with employee events, conversations with company leaders and chances to highlight the important contributions of women at BioMarin and beyond.

02/28/2026

Ahead of , we spoke with two members of the BioMarin Leadership Team – Chief Business Officer James Sabry and Chief R&D Officer Greg Friberg – and asked them to reflect on their time in medical school. They recall a common adage taught to young doctors – one that unintentionally resulted in clinicians overlooking uncommon or rare conditions, often referred to as “zebras.” Over time, this led to zebras becoming a powerful symbol for the rare disease community in the United States.

As we recognize Rare Disease Day today, we’re proud to show our stripes as a company that listens closely and looks for zebras when we hear hoofbeats.

Address

770 Lindaro Street
San Rafael, CA
94901

Alerts

Be the first to know and let us send you an email when BioMarin Pharmaceutical Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram